These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 2889032)

  • 21. The 11 beta-OHSD inhibitor, carbenoxolone, enhances Na retention by aldosterone and 11-deoxycorticosterone.
    Morris DJ; Souness GW
    Am J Physiol; 1990 Mar; 258(3 Pt 2):F756-9. PubMed ID: 2316675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [11 beta-hydroxysteroid dehydrogenase and steroid receptors].
    Takeda R; Takeda Y
    Nihon Naibunpi Gakkai Zasshi; 1992 Jul; 68(7):658-64. PubMed ID: 1516720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liquorice-induced sodium retention. Merely an acquired condition of apparent mineralocorticoid excess? A case report.
    Negro A; Rossi E; Regolisti G; Perazzoli F
    Ann Ital Med Int; 2000; 15(4):296-300. PubMed ID: 11202632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liquorice, growth retardation and Addison's disease.
    Doeker BM; Andler W
    Horm Res; 1999; 52(5):253-5. PubMed ID: 10844416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome?
    Palermo M; Delitala G; Sorba G; Cossu M; Satta R; Tedde R; Pala A; Shackleton CH
    J Endocrinol Invest; 2000; 23(7):457-62. PubMed ID: 11005270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apparent mineralocorticoid excess.
    Funder JW
    Endocrinol Metab Clin North Am; 1995 Sep; 24(3):613-21. PubMed ID: 8575412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defects in the HSD11 gene encoding 11 beta-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency.
    Nikkilä H; Tannin GM; New MI; Taylor NF; Kalaitzoglou G; Monder C; White PC
    J Clin Endocrinol Metab; 1993 Sep; 77(3):687-91. PubMed ID: 8370690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Licorice-induced hypermineralocorticoidism.
    Farese RV; Biglieri EG; Shackleton CH; Irony I; Gomez-Fontes R
    N Engl J Med; 1991 Oct; 325(17):1223-7. PubMed ID: 1922210
    [No Abstract]   [Full Text] [Related]  

  • 29. 3-Monoglucuronyl-glycyrrhetinic acid is a major metabolite that causes licorice-induced pseudoaldosteronism.
    Kato H; Kanaoka M; Yano S; Kobayashi M
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1929-33. PubMed ID: 7775643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Administration of glycyrrhetinic acid: significant correlation between serum levels and the cortisol/cortisone-ratio in serum and urine.
    Heilmann P; Heide J; Hundertmark S; Schöneshöfer M
    Exp Clin Endocrinol Diabetes; 1999; 107(6):370-8. PubMed ID: 10543414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apparent mineralocorticoid excess causing hypertension and hypokalemia in children.
    New MI; Stoner E; DiMartino-Nardi J
    Clin Exp Hypertens A; 1986; 8(4-5):751-72. PubMed ID: 3463439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cortisol as a mineralocorticoid in human disease.
    Stewart PM
    J Steroid Biochem Mol Biol; 1999; 69(1-6):403-8. PubMed ID: 10419018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective and specificity-conferring mechanisms of mineralocorticoid action.
    Morris DJ; Souness GW
    Am J Physiol; 1992 Nov; 263(5 Pt 2):F759-68. PubMed ID: 1443166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [11 beta-Hydroxysteroid dehydrogenase (11-beta-OHSD): physiology and lack of action in pathology].
    Vantyghem MC; Hober C; Racadot A; Lefebvre J
    Ann Endocrinol (Paris); 1994; 55(6):271-7. PubMed ID: 7864584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of glycyrrhizin on cortisol metabolism in humans.
    Soma R; Ikeda M; Morise T; Miyamori I; Takeda R
    Endocr Regul; 1994 Mar; 28(1):31-4. PubMed ID: 7949011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension.
    Ferrari P; Lovati E; Frey FJ
    J Hypertens; 2000 Mar; 18(3):241-8. PubMed ID: 10726708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 11 beta-Hydroxysteroid dehydrogenase and its inhibitors in hypertensive pregnancy.
    Walker BR; Williamson PM; Brown MA; Honour JW; Edwards CR; Whitworth JA
    Hypertension; 1995 Apr; 25(4 Pt 1):626-30. PubMed ID: 7721407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Syndrome of apparent mineralocorticoid excess caused by a deficiency of 11 beta-hydroxysteroid dehydrogenase: clinical and genetic study in a Chilean family followed for 19 years].
    Rodríguez JA
    Rev Med Chil; 2000 Jan; 128(1):17-26. PubMed ID: 10883518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is blood pressure commonly raised by moderate consumption of liquorice?
    Sigurjonsdottir HA; Ragnarsson J; Franzson L; Sigurdsson G
    J Hum Hypertens; 1995 May; 9(5):345-8. PubMed ID: 7623371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess.
    Whorwood CB; Stewart PM
    J Hypertens Suppl; 1996 Dec; 14(5):S19-24. PubMed ID: 9120678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.